Case Report: Chronic inflammatory demyelinating polyradiculoneuropathy rather than hemophagocytic lymphohistiocytosis-the initial phenotype of PRF1 gene mutation

Front Immunol. 2023 Dec 11:14:1306338. doi: 10.3389/fimmu.2023.1306338. eCollection 2023.

Abstract

Perforin is essentially involved in the granule-dependent killing activities of cytotoxic T lymphocytes and NK cells. Monoallelic PRF1 mutation increases the risk of autoimmune diseases, and biallelic PRF1 mutation causes familial hemophagocytic lymphohistiocytosis-2. Here, we report a case of a 12-year-old girl with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP), followed by a rapidly progressive onset of hemophagocytic lymphohistiocytosis (HLH) 9 months later, alongside manifestations of demyelinating encephalopathy. Genetic sequencing revealed a heterozygous nonsense mutation in the PRF1 gene (c.984G>A; p.W328*) and a heterozygous missense mutation in the PRF1 gene (c.1349C>T; p.T450M). Eventually, she died because of no suitable allogeneic hematopoietic stem cell available in time. Our observations suggest that CIPD might represent the initial phenotype of biallelic PRF1 mutation and could serve as an early sign of subsequent HLH. A comprehensive understanding of this condition is paramount for timely diagnosis, treatment, and ultimately improved patient outcomes.

Keywords: chronic inflammatory demyelinating polyradiculoneuropathy; demyelination of the central nervous system; familial hemophagocytic lymphohistiocytosis; perforin; perforinopathy.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Female
  • Humans
  • Lymphohistiocytosis, Hemophagocytic* / diagnosis
  • Lymphohistiocytosis, Hemophagocytic* / genetics
  • Lymphohistiocytosis, Hemophagocytic* / therapy
  • Mutation, Missense
  • Perforin / genetics
  • Phenotype
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating* / diagnosis
  • Polyradiculoneuropathy, Chronic Inflammatory Demyelinating* / genetics

Substances

  • Perforin
  • PRF1 protein, human

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The 14th Five-Year National Key Research and Development Plan (2021YFC2701902); The Capital’s Funds for Health Improvement and Research (2022-1-5081); The National Natural Science Foundation of China (Nos.81071036). All funders had no role in the design and conduct of the study.